Feb 4 (Reuters)-
Kidswell Bio Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2021 Dec 31, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.38 720 mln 1.90
(+91.9 pct) (-1.7 pct) (+90.7 pct)
Operating loss 432 mln loss 647 mln loss 1.72
Recurring loss 460 mln loss 660 mln loss 1.74
Net loss 94 mln loss 670 mln loss 1.32
EPS loss 3.08 yen loss 23.43 yen loss 42.91 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Kidswell Bio Corporation.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4584.T